These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7415045)

  • 1. [Comparison of metabolic and immunologic indices in breast cancer].
    Poroshina TE; Fedorov SN; Ostroumova MN; Dil'man VM
    Vopr Onkol; 1980; 26(8):24-7. PubMed ID: 7415045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of sera of breast cancer patients on NK cell activity].
    Konjević G; Spuzić I
    Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The correction of dyslipidemia in breast cancer patients].
    Sterniuk IuM; Gnatyshak AI; Sendetskaia RI
    Vrach Delo; 1989 Nov; (11):86-8. PubMed ID: 2609595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cyclic adenosine monophosphate content in the lymphocytes of cancer patients].
    Bershteĭn LM; Revskoĭ SIu; Kovaleva IG; Dil'man VM
    Eksp Onkol; 1985; 7(5):53-6. PubMed ID: 2998725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cellular immunity indices in benign breast tumors].
    Baisheva SA; Zhalgasbaeva GT; Kaliev IuSh; Mezinova NN
    Vopr Onkol; 1980; 26(5):15-9. PubMed ID: 7385708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunologic parameters in breast cancer patients (depending on age, reproductive function, clinical and pathologic pattern and growth rate of the tumor)].
    Baldueva IA; Semiglazov VF
    Vopr Onkol; 1996; 42(5):31-5. PubMed ID: 9064899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Improvement in the functional and morphological mononuclear blood cell indices under the influence of miscleron].
    Nemirovskiĭ VS; Ostroumova MN; Blagosklonnaia IaV; Uskova AL; Freĭdlin IS
    Vopr Onkol; 1978; 24(4):65-8. PubMed ID: 654176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gail coefficient as a risk factor and prognosticator for the course of breast cancer: correlation with hormonal and metabolic parameters and clinical and morphologic features].
    Boiarkina MP; Tsyrlina EV; Poroshina TE; Semiglazov VF; Bershteĭn LM
    Vopr Onkol; 2008; 54(1):25-30. PubMed ID: 18416053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The phagocytic activity of monocytes in different stages of breast cancer].
    Baskić D; Aćimović LD; Arsenijević N
    Med Pregl; 2003; 56 Suppl 1():103-7. PubMed ID: 15510923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased number of phagocytic cells among the peripheral blood lymphocytes of mammary tumor patients.
    Süss J; Bakács T; Ringwald G
    Allerg Immunol (Leipz); 1984; 30(3):183-7. PubMed ID: 6239528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration in monocyte function in patients with breast cancer.
    Al-Sumidaie AM; Leinster SJ; Webster DJ; Jenkins SA
    Eur J Surg Oncol; 1987 Oct; 13(5):419-24. PubMed ID: 3666157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mutational-metabolic model of carcinogenesis and the progression of the neoplastic process].
    Dil'man VM
    Vopr Onkol; 1976; 22(8):3-16. PubMed ID: 997416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum lipids and outcome of early-stage breast cancer: results of a prospective cohort study.
    Bahl M; Ennis M; Tannock IF; Hux JE; Pritchard KI; Koo J; Goodwin PJ
    Breast Cancer Res Treat; 2005 Nov; 94(2):135-44. PubMed ID: 16261412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Differentiation of lymphocyte populations in the blood of breast-cancer patients].
    Weber W; Nagel GA; Obrist R; Nagel E; Heitz P; Oberholzer M; Herzig D
    Schweiz Med Wochenschr; 1977 Jul; 107(28):1010-2. PubMed ID: 331468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypophyseal hormones in young patients with breast cancer].
    Chobanian NS; Kushlinskiĭ NE; Bassalyk LS; Kuzmina ZV; Gershteĭn ES; Saveléva EV; Baryshnikov AIu; Kadagidze ZG
    Klin Med (Mosk); 1994; 72(3):37-40. PubMed ID: 7990352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta glucan induces proliferation and activation of monocytes in peripheral blood of patients with advanced breast cancer.
    Demir G; Klein HO; Mandel-Molinas N; Tuzuner N
    Int Immunopharmacol; 2007 Jan; 7(1):113-6. PubMed ID: 17161824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer and family history: levels of lipid-associated sialic acid in plasma and absent family history of breast cancer in women who have breast tumors.
    Brower ST; Tartter P; Weiss S; Luderer AA; Lehrer S
    Mt Sinai J Med; 1995 Nov; 62(6):419-21. PubMed ID: 8692154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.